lincare holdings

UBS Lowered Its PT For Lincare Holdings To $35, Maintained Its Buy Rating

Published on Tue, 07/19/2011 - 12:17
By FNNO Staff in General Interest, LNCR, analyst, business, eps, finance, investing, lincare holdings, market, news, revenue, stock, trading, ubs, Analyst Insight

Lincare Holdings has a potential upside of 31.8% based on a current price of $25.9 and an average consensus analyst price target of $34.13.

Lincare Holdings should find initial resistance at its 200-day moving average (MA) of $28.33 and further resistance at its 50-day MA of $29.66.

analyst, business, eps, finance, investing, lincare holdings, market, news, revenue, stock, trading, ubs

UBS lowered its price target for Lincare Holdings (NASDAQ:LNCR) to $35 from $37 and maintained its buy rating on the stock.

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Earnings Look Back: Comcast Is Up 3.1% S...

When Comcast (NASDAQ:CMCSK) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 6th, 2013 Liberty Global (NASDAQ:LBTYA) reported earnings and analyst ...

Earnings Look Back: Kelly Services Is Up...

When Kelly Services (NASDAQ:KELYA) reported earnings a week ago on May 8th, 2013, analy ...

Liberty Media Earnings Review: 10 Days a...

When Liberty Media (NASDAQ:LINTA) reported earnings a week ago on May 8th, 2013, analys ...

Central Garden and Pet Earnings Hindsigh...

A week ago on May 8th, 2013 Central Garden and Pet (NASDAQ:CENTA) reported earnings and ...

Comcast Earnings Review: 17 Days after A...

When Comcast (NASDAQ:CMCSA) reported earnings 17 days ago on May 1st, 2013, analysts, o ...

Earnings Flashback: Since Reporting Quar...

A week ago on May 7th, 2013 Discovery Communications (NASDAQ:DISCA) reported earnings a ...

Jazz Pharmaceuticals Earnings In Retrosp...

11 days ago, on May 7th, 2013, Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its earnings ...

Most Popular Video News